HUMAN THERAPEUTICS EXCLUSIVE LICENSE AGREEMENTLetter Agreement • January 26th, 2021 • Design Therapeutics, Inc. • Pharmaceutical preparations • Wisconsin
This Human Therapeutics Exclusive License Agreement (“Agreement”) is made effective the 20th day of February, 2019 (“Effective Date”), by and between Wisconsin Alumni Research Foundation (“WARF”), a nonstock, nonprofit Wisconsin corporation, and Design Therapeutics, Inc. (“Licensee”), a corporation organized and existing under the laws of Delaware.
DESIGN THERAPEUTICS CONSULTING AGREEMENT EFFECTIVE DATE: March 1, 2020Consulting Agreement • January 26th, 2021 • Design Therapeutics, Inc. • Pharmaceutical preparations • California
THIS CONSULTING AGREEMENT (the “Agreement”) is made as of the Effective Date set forth above by and between Design Therapeutics, Inc., a Delaware corporation (“Client”), and Marlinspike Group, LLC, a Delaware limited liability company (“Consultant”).
DESIGN THERAPEUTICS, INC.Design Therapeutics, Inc. • January 26th, 2021 • Pharmaceutical preparations
Design Therapeutics, Inc. (the “Company”) is pleased to offer you at-will employment in the position of Chief Executive Officer (“CEO”) on the terms and conditions set forth in this letter agreement (the “Agreement”).
